Scarica l'app Stockscreener
508.29
0.80%
-4.09
Dopo l'orario di chiusura:
508.30
0.010
+0.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$512.38
Aprire:
$507.56
Volume 24 ore:
96,931
Relative Volume:
0.80
Capitalizzazione di mercato:
$6.64B
Reddito:
$2.54B
Utile/perdita netta:
$259.78M
Rapporto P/E:
27.70
EPS:
18.3497
Flusso di cassa netto:
$377.12M
1 W Prestazione:
+1.53%
1M Prestazione:
+0.84%
6M Prestazione:
+32.16%
1 anno Prestazione:
+15.37%
Intervallo 1D:
$506.09
$511.81
Intervallo di 1 settimana:
$500.89
$520.88
Portata 52W:
$365.20
$557.00
Chemed Corp Stock (CHE) Company Profile
Nome
Chemed Corp
Settore
Industria
Telefono
(513)762-6690
Indirizzo
SUITE 2600, CINCINNATI, OH
Compare CHE vs HCA, THC, EHC, DVA, FMS
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CHE
Chemed Corp
|
508.29 | 6.64B | 2.54B | 259.78M | 377.12M | 18.35 |
HCA
Hca Healthcare Inc
|
454.88 | 98.48B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
266.39 | 21.45B | 21.46B | 2.65B | 3.35B | 19.23 |
EHC
Encompass Health Corp
|
121.71 | 12.01B | 6.07B | 793.80M | 464.40M | 5.9914 |
DVA
Davita Inc
|
187.00 | 11.93B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.94 | 11.68B | 22.44B | 1.35B | 2.03B | 1.9002 |
Chemed Corp Stock (CHE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-09-25 | Iniziato | UBS | Buy |
| 2026-02-27 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-22 | Downgrade | Jefferies | Buy → Hold |
| 2025-09-02 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-07-25 | Iniziato | Jefferies | Hold |
| 2020-03-11 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-11-01 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-09-06 | Reiterato | BofA/Merrill | Buy |
| 2018-10-12 | Iniziato | BofA/Merrill | Buy |
| 2017-08-28 | Iniziato | KeyBanc Capital Mkts | Sector Weight |
| 2016-11-01 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-05-02 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-10-26 | Reiterato | Oppenheimer | Outperform |
| 2015-10-26 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-09-22 | Reiterato | Oppenheimer | Outperform |
| 2015-07-27 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2015-02-19 | Reiterato | Oppenheimer | Outperform |
| 2014-09-23 | Reiterato | Oppenheimer | Outperform |
| 2014-06-10 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2014-05-01 | Reiterato | Oppenheimer | Outperform |
| 2013-09-10 | Reiterato | Deutsche Bank | Hold |
| 2011-03-04 | Reiterato | Barclays Capital | Underweight |
| 2011-02-17 | Reiterato | Oppenheimer | Outperform |
| 2011-02-17 | Reiterato | RBC Capital Mkts | Sector Perform |
Mostra tutto
Chemed Corp Borsa (CHE) Ultime notizie
Roto-Rooter Services Company Expands California Service Coverage to Reach 11M+ More Residents - Yahoo Finance
UBS sets USD 650.00 target for Chemed stock, 26.11 percent above price - ad-hoc-news.de
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
Chemed Corporation $CHE Stock Sold by Signal Advisors Wealth LLC - MarketBeat
Chemed Corporation (NYSE:CHE) Stock Now Rated "Hold" by Sell-Side Analysts - MarketBeat
Chemed (NYSE:CHE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
Chemed Corp (CHE) Stock forecasts - Yahoo Finance UK
Chemed (CHE): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Chemed Corp (CHE) Stock Forecasts - Yahoo! Finance Canada
Chemed (NYSE:CHE) Stock Breaks Above 200 Day Moving AverageHere's Why - MarketBeat
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
Chemed (NYSE:CHE) Stock Price - Simply Wall Street
Chemed Corp (CHE) Stock forecasts - sg.finance.yahoo.com
Chemed Corporation (CHE) stock price, news, quote and history - Yahoo Finance UK
Chemed Corporation (CHE) stock price, news, quote and history - Yahoo Finance Australia
An executive exercises 12,099 Chemed (CHE) options, with 11,160 shares delivered or withheld for costs and taxes. - Stock Titan
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28 - GlobeNewswire
Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28 - Yahoo Finance
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
Chemed Corp (CHE) President and CEO Kevin Mcnamara Sells 2,000 S - GuruFocus
Chemed (NYSE:CHE) Stock: Insider Kevin Mcnamara Sells 2,000 Shares - MarketBeat
Chemed Corp CEO Kevin J. McNamara Sells 2,000 Shares at $513.45 Average Price in September 2026 - Kalkine Media
Chemed Corporation (CHE) Stock Price, News, Quote & History - Yahoo! Finance Canada
Chemed stock trades below the USD 530.75 consensus target - AD HOC NEWS
Chemed (CHE) Stock May Be 26% Undervalued On Franchise Territory Deal - Yahoo Finance
UBS Initiates Chemed at Buy With $650 Price Target - marketscreener.com
UBS initiates Chemed stock coverage with buy rating on growth outlook - Investing.com
Chemed (NYSE:CHE) Stock Forecast & Analyst Predictions - Simply Wall Street
Chemed Corp (CHE) Stock Forecasts - Yahoo! Finance Canada
Chemed Corp (CHE) Stock Forecasts - Yahoo Finance
NewEdge Advisors LLC Has $974,000 Stake in Chemed Corporation $CHE - MarketBeat
Chemed (CHE) Buys a $60.6M Roto-Rooter Franchise. Can Ownership Lift Returns? - Insider Monkey
Chemed (CHE) Buys a $60.6M Roto-Rooter Franchise. Can Ownership Lift Returns? - Yahoo Finance
Chemed Corp (CHE) Insider Sale: President and CEO Kevin Mcnamara Sells 2,000 Shares - GuruFocus
Kevin Mcnamara Sells 2,000 Shares of Chemed (NYSE:CHE) Stock - MarketBeat
Chemed Insider Sold Shares Worth $1,002,800, According to a Recent SEC Filing - marketscreener.com
Chemed (NYSE: CHE) CEO sells shares outside a preset trading plan - Stock Titan
Chemed Corp (CHE) Stock Analysis: Exploring 9.51% Potential Upside and Strong Return on Equity - DirectorsTalk Interviews
103,610 Shares in Chemed Corporation $CHE Purchased by Bank of America Corp DE - MarketBeat
Engineers Gate Manager LP Sells 11,031 Shares of Chemed Corporation $CHE - MarketBeat
Chemed Corporation stock holds steady as analysts stick to Hold consensus - AD HOC NEWS
Chemed Corporation (NYSE:CHE) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Chemed Unit Buys Franchise Territory in California - Yahoo Finance
Roto-Rooter Buys Largest Franchisee Territory - GlobeNewswire
California State Teachers Retirement System Purchases 7,597,086 Shares of Chemed Corporation $CHE - MarketBeat
Chemed (CHE) Stock Price, News & Analysis $CHE - MarketBeat
Privia Health Group Inc. (PRVA) Peer Comparison – Compare with Others - valueresearchonline.com
Chemed Corporation to Present at the Jefferies 2026 Healthcare Services Conference - Yahoo Finance
Chemed Corp Azioni (CHE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Chemed Corp Azioni (CHE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kevin McNamara | Officer |
Sep 28 '26 |
Proposed Sale |
536.13 |
2,000 |
1,072,260 |
0 |
| HUTTON THOMAS C | vice president |
Sep 28 '26 |
Option Exercise |
445.35 |
4,629 |
2,061,525 |
37,110 |
| MCNAMARA KEVIN J | president and CEO |
Sep 28 '26 |
Sale |
513.45 |
2,000 |
1,026,900 |
66,418 |
| MCNAMARA KEVIN J | president and CEO |
Sep 18 '26 |
Sale |
501.40 |
2,000 |
1,002,800 |
68,418 |
| MCNAMARA KEVIN J | Officer |
Sep 18 '26 |
Proposed Sale |
499.00 |
2,000 |
998,000 |
0 |
| MCNAMARA KEVIN J | president and CEO |
Aug 21 '26 |
Sale |
541.16 |
2,000 |
1,082,320 |
70,418 |
| LEE SPENCER S | executive vice president |
Aug 21 '26 |
Sale |
541.04 |
1,000 |
541,040 |
13,912 |
| Kevin J McNamara | Officer |
Aug 21 '26 |
Proposed Sale |
539.34 |
2,000 |
1,078,680 |
0 |
| Judkins Brian C | VP and Chief Legal Officer |
Aug 10 '26 |
Option Exercise |
445.35 |
6,786 |
3,022,145 |
9,222 |
| Wherley Joel L | CEO - Vitas Healthcare |
Aug 05 '26 |
Option Exercise |
445.35 |
2,599 |
1,157,465 |
3,451 |
2.26%
0.03%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):